These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 30002069
1. Discrepancy in current central serous chorioretinopathy classification. Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J. Br J Ophthalmol; 2019 Jun; 103(6):737-742. PubMed ID: 30002069 [Abstract] [Full Text] [Related]
2. Validation of central serous chorioretinopathy multimodal imaging-based classification system. Chhablani J, Behar-Cohen F, Central Serous Chorioretinopathy International Group. Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1161-1169. PubMed ID: 34669028 [Abstract] [Full Text] [Related]
3. Influence of fellow eye on the diagnosis and classification of central serous chorioretinopathy. Parameswarappa DC, Arora S, Singh SR, Sahoo NK, Maltsev DS, Kulikov AN, Iovino C, Tatti F, Venkatesh R, Zaheer H, Reddy NG, Pulipaka RS, Peiretti E, Chhablani J. Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1147-1152. PubMed ID: 34633519 [Abstract] [Full Text] [Related]
4. Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy. Mandadi SKR, Singh SR, Sahoo NK, Mishra SB, Sacconi R, Iovino C, Berger L, Munk MR, Querques G, Peiretti E, Chhablani J. Br J Ophthalmol; 2021 Sep; 105(9):1280-1285. PubMed ID: 30798261 [Abstract] [Full Text] [Related]
6. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Kneba M, Grzybowski A. BMC Ophthalmol; 2019 Jul 25; 19(1):160. PubMed ID: 31345183 [Abstract] [Full Text] [Related]
7. PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHY: An Optical Coherence Tomography Angiography Study. Matet A, Daruich A, Hardy S, Behar-Cohen F. Retina; 2019 Nov 25; 39(11):2178-2188. PubMed ID: 30028410 [Abstract] [Full Text] [Related]
8. Masqueraders of central serous chorioretinopathy. Sahoo NK, Singh SR, Rajendran A, Shukla D, Chhablani J. Surv Ophthalmol; 2019 Nov 25; 64(1):30-44. PubMed ID: 30243734 [Abstract] [Full Text] [Related]
9. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy. Demirok G, Kocamaz F, Topalak Y, Altay Y, Sengun A. Int Ophthalmol; 2017 Apr 25; 37(2):409-416. PubMed ID: 27324370 [Abstract] [Full Text] [Related]
10. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY. Dysli C, Berger L, Wolf S, Zinkernagel MS. Retina; 2017 Nov 25; 37(11):2151-2161. PubMed ID: 28099314 [Abstract] [Full Text] [Related]
11. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B. Graefes Arch Clin Exp Ophthalmol; 2019 Aug 25; 257(8):1581-1590. PubMed ID: 31037488 [Abstract] [Full Text] [Related]
12. Management of central serous chorioretinopathy: Expert panel discussion. Chhablani J, Anantharaman G, Behar-Cohen F, Boon C, Manayath G, Singh R. Indian J Ophthalmol; 2018 Dec 25; 66(12):1700-1703. PubMed ID: 30451169 [Abstract] [Full Text] [Related]
13. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ferrara D, Mohler KJ, Waheed N, Adhi M, Liu JJ, Grulkowski I, Kraus MF, Baumal C, Hornegger J, Fujimoto JG, Duker JS. Ophthalmology; 2014 Mar 25; 121(3):719-26. PubMed ID: 24289918 [Abstract] [Full Text] [Related]
14. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes. Shinojima A, Mehanna C, Lavia CA, Gaudric A, Tadayoni R, Bousquet E. Br J Ophthalmol; 2020 Jun 25; 104(6):852-856. PubMed ID: 31473627 [Abstract] [Full Text] [Related]
15. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Azar G, Wolff B, Mauget-Faÿsse M, Rispoli M, Savastano MC, Lumbroso B. Acta Ophthalmol; 2017 Jun 25; 95(4):421-427. PubMed ID: 27597633 [Abstract] [Full Text] [Related]
16. Central Serous Chorioretinopathy. Daruich A, Matet A, Behar-Cohen F. Dev Ophthalmol; 2017 Jun 25; 58():27-38. PubMed ID: 28351043 [Abstract] [Full Text] [Related]
17. FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY. Han J, Cho NS, Kim K, Kim ES, Kim DG, Kim JM, Yu SY. Retina; 2020 Jul 25; 40(7):1387-1394. PubMed ID: 31157711 [Abstract] [Full Text] [Related]
18. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy. Lyu Y, Li X, Gong Y. Ophthalmologica; 2020 Jul 25; 243(5):360-369. PubMed ID: 32008002 [Abstract] [Full Text] [Related]
19. Detection of Choroidal Neovascularization in Central Serous Chorioretinopathy Using Optical Coherence Tomographic Angiography. Weng S, Mao L, Yu S, Gong Y, Cheng L, Chen X. Ophthalmologica; 2016 Jul 25; 236(2):114-21. PubMed ID: 27562525 [Abstract] [Full Text] [Related]
20. Pattern electroretinography in patients with unilateral acute central serous chorioretinopathy. Doguizi S, Sekeroglu MA, Ozkoyuncu D, Yilmazbas P. Clin Exp Optom; 2020 Sep 25; 103(5):656-662. PubMed ID: 31822040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]